Abstract Body

Perinatal depression -PD and poor maternal mental health in the perinatal period may have a negative impact on pregnancy outcomes, parenting functions, the mother-infant bonding, the child’s development and family functioning.

Additional risk of severe episodes, chronicity and treatment-resistance, relapse or recurrence underlines the importance of prevention, early recognition and effective treatment with a follow-up, evaluating response to treatment and rate remission.

The aim of this presentation is to provide a comprehensive overview of many treatment options focusing on non-drug treatments, psychotherapy and alternatives, non-pharmacological, biological treatment options, as light therapy and TMS.

PD can be heterogeneous in individual risk factors and triggers, symptomatology, underlying or co-morbid disorders, the treatment plan should be personalized considering of the patients‘ case and history, the patients' and their families’ treatment preference.

Most recommendation is about evidence based psychotherapy, (CBT, IPT), however there is a growing evidence for other interventions focusing on the mother-baby relationship, attachment, as parent-infant psychotherapy, integrated parent-child consultation with video-feedback and peer-to-peer interventions.

In our interdisciplinary, team-based clinical practice we attended to a growing number of patients and their families year to year – in 2012 was 26, in 2019 was 131 per year, 14% in inpatient and 86 % in outpatient service, in overall 380 cases.

We will present case samples from our practice of case-management based on an individualized treatment plan.

There is a need to personalize the treatment of PD, to collect evidences and good practices for the non-pharmacological therapies, including the new forms of psychotherapeutic interventions.